Division of Vascular and Endovascular Surgery, University of California, Los Angeles.
Division of Vascular and Endovascular Surgery, University of California, Los Angeles.
Ann Vasc Surg. 2022 Jul;83:53-61. doi: 10.1016/j.avsg.2021.12.080. Epub 2022 Jan 6.
Congenital abnormalities of the first rib (ABNFR) are a rare cause of thoracic outlet syndrome (TOS). The range of abnormalities have not been clearly documented in the literature. Surgical decompression in these patients presents with increased complexity secondary to anomalous anatomy. Our goal is to review an institutional experience of first rib resection (FRR) performed for ABNFRs, to present a novel classification system, and to analyze outcomes according to clinical presentation.
A prospectively collected database was used to identify individuals with ABNFRs who underwent FRR for TOS between 1990-2021. These individuals were identified both by preoperative imaging and intraoperative descriptions of the first rib after resection. Demographic, clinical, perioperative and pathological data were reviewed. ABNFRs were classified into 3 categories according to anatomical criteria: (I) Hypoplastic, (II) Fused, and (III) Hyperplastic. Outcomes were rated using the standardized Quick Disability of Arm Shoulder and Hand Scores (QDS), Somatic Pain Scores (SPS) and Derkash Scores (DkS).
Among the 2200 cases of TOS, there were 19 patients (0.8%) with ABNFR who underwent FRR. Average age at surgery was 30.5 (range 11-74), including 13 men and 6 women. Presentations included 9 arterial (ATOS), 6 neurogenic (NTOS), and 4 venous (VTOS) cases. There were 6 class I, 6 class II, and 7 class III ABNFRs. Among 6 NTOS patients there were 4 abnormal nerve conduction tests and 5 positive anterior scalene muscle blocks. Among the 9 patients with ATOS, thrombolysis was attempted in 5 patients, and of these, 3 ultimately required surgical thrombectomy. Of 4 VTOS cases, 2 were managed with thrombolysis, and 2 with anticoagulation alone. The approach for FRR was transaxillary in all patients. Secondary procedures included 1 pectoralis minor tenotomy, 1 scalenectomy, and 1 contralateral rib resection. No major neurological or vascular complications occurred. There was 1 patient who required surgical evacuation of a hematoma. Intraoperative chest tube placement was required in 5 patients secondary to pleural entry during dissection. There was an overall improvement in symptoms over an average follow-up of 7.4 months. QDS reduced from 49.7 pre-op to 22.1 (P < 0.05). SPS improved from 3.4 pre-op to 1.8. DkS scores were good to excellent in 79% of patients. Residual symptoms were noted in 7, and ATOS accounted for 5 (70%) of these. All patients were able to return to work.
Despite increased complexity, ABNFRs may be safely resected via transaxillary approach with low incidence of complications, very good symptom relief, and excellent outcomes. Congenital ABNFRs may by classified into 3 categories (hypoplastic, fused, and hyperplastic) with a variety of presentations, including ATOS, NTOS, and VTOS. Classification of ABNFRs allows concise description of abnormal anatomy which facilitates comparison between series and provides direction for surgical management to ultimately optimize patient outcomes.
第一肋骨先天性异常(ABNFR)是胸廓出口综合征(TOS)的罕见原因。文献中并未明确记录异常的范围。这些患者的手术减压由于异常解剖结构而变得更加复杂。我们的目标是回顾我们机构对因 ABNFR 而行第一肋骨切除术(FRR)的经验,提出一种新的分类系统,并根据临床表现分析结果。
使用前瞻性收集的数据库来确定 1990 年至 2021 年间因 TOS 而行 FRR 的 ABNFR 患者。这些患者术前影像学和术中切除第一肋骨后的描述均被识别出来。回顾了人口统计学、临床、围手术期和病理数据。根据解剖学标准将 ABNFR 分为 3 类:(I)发育不良,(II)融合,和(III)增生。使用标准化的简易上肢残疾问卷(QDS)、躯体疼痛评分(SPS)和 Derkash 评分(DkS)来评定结果。
在 2200 例 TOS 中,有 19 例(0.8%)患者因 ABNFR 而行 FRR。手术时的平均年龄为 30.5 岁(范围 11-74 岁),包括 13 名男性和 6 名女性。表现包括 9 例动脉型(ATOS)、6 例神经型(NTOS)和 4 例静脉型(VTOS)。有 6 例 I 类、6 例 II 类和 7 例 III 类 ABNFR。在 6 例 NTOS 患者中,有 4 例神经传导异常,5 例前斜角肌阻滞阳性。在 9 例 ATOS 患者中,有 5 例尝试了溶栓治疗,其中 3 例最终需要手术取栓。在 4 例 VTOS 患者中,2 例接受溶栓治疗,2 例单独接受抗凝治疗。所有患者均采用经腋入路行 FRR。二级手术包括 1 例胸小肌切断术、1 例前斜角肌切除术和 1 例对侧肋骨切除术。无主要神经或血管并发症发生。有 1 例患者需要手术清除血肿。由于在解剖过程中进入胸腔,5 例患者需要放置胸腔引流管。平均随访 7.4 个月后,症状总体改善。QDS 评分从术前的 49.7 分降至 22.1 分(P<0.05)。SPS 从术前的 3.4 分改善至 1.8 分。DkS 评分在 79%的患者中为良好至优秀。7 例患者仍有残留症状,其中 5 例(70%)为 ATOS。所有患者均能恢复工作。
尽管存在复杂性增加,但经腋入路安全切除 ABNFR 的并发症发生率低,症状缓解非常好,且结果极佳。先天性 ABNFR 可分为 3 类(发育不良、融合和增生),表现多样,包括 ATOS、NTOS 和 VTOS。ABNFR 的分类可以简洁地描述异常解剖结构,便于系列间的比较,并为手术管理提供指导,最终优化患者的结果。